GlassScriptPhysician profile
Krystal Uong
NPI 1144998378
$1,522.90
in general payments reported to CMS, 2019-2025
20 companies · $706 in 2025
The $706 reported for 2025 was more than what 81% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $486 · 2024: $330 · 2025: $706.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,523.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,522.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $409.46 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $200.47 | 2024-2025 | Capvaxive, Gardasil 9, Vaxelis |
| Gilead Sciences, INC. | $171.60 | 2023 | Epclusa |
| Glaxosmithkline, LLC. | $88.36 | 2023-2024 | Shingrix, Arexvy, Bexsero |
| Lilly USA, LLC | $71.06 | 2023-2025 | Zepbound, Mounjaro, Jardiance |
| Exact Sciences Corporation | $68.77 | 2025 | Cologuard Collection Kit |
| Pfizer INC. | $65.37 | 2023-2025 | |
| Abbvie INC. | $64.45 | 2023-2024 | |
| Dynavax Technologies Corporation | $57.87 | 2023-2024 | Heplisav-B |
| Viiv Healthcare Company | $57.82 | 2023-2025 | Apretude |
| Redhill Biopharma INC. | $50.38 | 2025 | Talicia |
| Regeneron Healthcare Solutions, INC. | $38.94 | 2024 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $37.91 | 2023 | Breztri |
| Hologic Sales and Service, LLC | $32.38 | 2024 | Aptima |
| Otsuka America Pharmaceutical, INC. | $23.98 | 2024 | Rexulti |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.27 | 2023 | Tradjenta, Jardiance |
| Organon LLC | $16.94 | 2023 | Nexplanon |
| Amgen INC. | $16.74 | 2025 | Otezla, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $14.82 | 2024 | |
| Dexcom, INC. | $14.31 | 2023 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krystal Uong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.